Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.
Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P; PRIAMO Study Group. Morgante L, et al. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):76-82. doi: 10.1136/jnnp-2011-300043. Epub 2011 Aug 11. J Neurol Neurosurg Psychiatry. 2012. PMID: 21836035
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.
Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis.
Bomboi G, Ikonomidou VN, Pellegrini S, Stern SK, Gallo A, Auh S, Evangelou IE, Agarwal J, Pellicano C, Ohayon JM, Cantor FK, Ehrmantraut M, McFarland HF, Kane RL, Bagnato F. Bomboi G, et al. Among authors: pellicano c. J Neuroimaging. 2011 Apr;21(2):e57-63. doi: 10.1111/j.1552-6569.2010.00488.x. J Neuroimaging. 2011. PMID: 20626570
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Campbell Z, Sahm D, Donohue K, Jamison J, Davis M, Pellicano C, Auh S, Ohayon J, Frank JA, Richert N, Bagnato F. Campbell Z, et al. Among authors: pellicano c. Neurology. 2012 May 8;78(19):1493-9. doi: 10.1212/WNL.0b013e3182553bd2. Epub 2012 Apr 25. Neurology. 2012. PMID: 22539575 Free PMC article.
115 results